Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Prepaid Assets: 2017-2025

Historic Prepaid Assets for Dianthus Therapeutics (DNTH) over the last 7 years, with Sep 2025 value amounting to $6.2 million.

  • Dianthus Therapeutics' Prepaid Assets rose 68.67% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 68.67%. This contributed to the annual value of $4.9 million for FY2024, which is 49.19% up from last year.
  • As of Q3 2025, Dianthus Therapeutics' Prepaid Assets stood at $6.2 million, which was up 0.57% from $6.2 million recorded in Q2 2025.
  • In the past 5 years, Dianthus Therapeutics' Prepaid Assets registered a high of $6.8 million during Q1 2025, and its lowest value of $832,000 during Q3 2023.
  • Moreover, its 3-year median value for Prepaid Assets was $3.3 million (2024), whereas its average is $3.8 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first plummeted by 78.18% in 2023, then soared by 342.67% in 2024.
  • Dianthus Therapeutics' Prepaid Assets (Quarterly) stood at $905,000 in 2022, then surged by 259.67% to $3.3 million in 2023, then surged by 49.19% to $4.9 million in 2024, then surged by 68.67% to $6.2 million in 2025.
  • Its Prepaid Assets stands at $6.2 million for Q3 2025, versus $6.2 million for Q2 2025 and $6.8 million for Q1 2025.